Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 |
| Revenues | 0.0 | 0.0 |
| Cost of goods sold | 0.0 | 0.0 |
| Gross profit | 0.0 | 0.0 |
| Research and development | 42.0 | |
| General and administrative | 23.0 | 4.6 |
| EBIT | -65.1 | -4.6 |
| Pre-tax income | -64.5 | -4.5 |
| Income taxes | 0.0 | 0.0 |
| Tax rate | 0.1% | 0.0% |
| Net income | -49.9 | -4.5 |
| |
| Diluted EPS | ($1.70) | ($0.01) |
| Shares outstanding (diluted) | 29.4 | 360.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|